nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2017-3-39-46nefr-262Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ NGAL, БЕЛКОВ СИСТЕМЫ КОМПЛЕМЕНТА С3 И С4, ИММУНОГЛОБУЛИНОВ КРОВИ У ДЕТЕЙ С ГЕМОЛИТИКО-УРЕМИЧЕСКИМ СИНДРОМОМDIAGNOSTIC VALUE OF BLOOD NGAL, COMPLEMENT PROTEINS C3 AND C4, IMMUNOGLOBULINS IN CHILDREN WITH HEMOLYTIC-UREMIC SYNDROMEБайкоС. В.BaikoS. V.

Доцент, 1-я кафедра детских болезней,

220020, Минск, ул. Нарочанская, д. 17

Dr., MD, PhD, 1st Department of Pediatrics, 

220016, Minsk, Narochanskaya St., 17

baiko@yandex.ruСукалоА. В.SukaloA. V.

Академик НАН, 1-я кафедра детских болезней, заведующий,

220020, Минск, ул. Нарочанская, д. 17

Prof., MD, PhD, DMedSci, Acad., 1st Department of Pediatrics, 

220016, Minsk, Narochanskaya St., 17

kafedra.pediatria1@yandex.ruБураковскийА. И.BurackovskiA. I.

220141, Минск, ул. Купревича, д. 5/2

PhD,

220141, Minsk, Kuprevich Str. 5/2

alesbur@ya.ruБелорусский государственный медицинский университетБеларусьBelarusian State Medical UniversityBelarusБелорусский государственный медицинский университет; Национальная академия Наук БеларусиБеларусьBelarusian State Medical University; Belarusian National Academy of SciencesBelarusИнститут биоорганической химии Национальной академии наук БеларусиБеларусьInstitute of Bioorganic Chemistry, Belarusian National Academy of SciencesBelarus2017250420172133946Copyright © Байко С.В., Сукало А.В., Бураковский А.И., 20172017Байко С.В., Сукало А.В., Бураковский А.И.Baiko S.V., Sukalo A.V., Burackovski A.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/262гемолитико-уремический синдромдетилипокалинассоциированный с желатиназой нейтрофиловкомпоненты комплемента С3 и С4иммуноглобулиныострое повреждение почекhemolytic uremic syndrome (HUS)childrenneutrophil gelatinase-associated lipocalin (NGAL)complement C3 and C4immunoglobulinsacute kidney injuryReferencesRuggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60(3): 831–846Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60(3): 831–846Байко СВ. Гемолитико-уремический синдром: эпидемиология, классификация, клиника, диагностика, лечение (Часть 1). Нефрология и диализ 2007; 9(4): 370–377 [Bajko SV. Gemolitiko-uremicheskij sindrom: e'pidemiologiya, klassifikaciya, klinika, diagnostika, lechenie (Chast’ 1). Nefrologiya i dializ 2007; 9(4): 370-377]Байко СВ. Гемолитико-уремический синдром: эпидемиология, классификация, клиника, диагностика, лечение (Часть 1). Нефрология и диализ 2007; 9(4): 370–377 [Bajko SV. Gemolitiko-uremicheskij sindrom: e'pidemiologiya, klassifikaciya, klinika, diagnostika, lechenie (Chast’ 1). Nefrologiya i dializ 2007; 9(4): 370-377]Loirat C, Fakhouri F, Ariceta G et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2016; 31(1): 15–39Loirat C, Fakhouri F, Ariceta G et al. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2016; 31(1): 15–39Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2(1): 1-138Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2(1): 1-138Uchino S. Serum creatinine. Curr Opin Crit Care 2010; 16(6): 562-567Uchino S. Serum creatinine. Curr Opin Crit Care 2010; 16(6): 562-567Kjeldsen L, Johnsen AH, Sengeløv H et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268(14): 10425-1032Kjeldsen L, Johnsen AH, Sengeløv H et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268(14): 10425-1032Kjeidsen L, Cowland JB, Borregard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482(1-2): 272-283Kjeidsen L, Cowland JB, Borregard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482(1-2): 272-283Haase-Fielitz A, Bellomo R, Devarjan P et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009; 24(11): 3349-3354Haase-Fielitz A, Bellomo R, Devarjan P et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009; 24(11): 3349-3354Mishra J, Ma O, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14(10): 2534-2543Mishra J, Ma O, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14(10): 2534-2543Adachi T. Structures and functions of antibodies. Nihon Rinsho 2005; 63(Suppl 4): 237-242Adachi T. Structures and functions of antibodies. Nihon Rinsho 2005; 63(Suppl 4): 237-242Cho H. Complement regulation: physiology and disease relevance. Korean J Pediatr 2015; 58(7): 239-244Cho H. Complement regulation: physiology and disease relevance. Korean J Pediatr 2015; 58(7): 239-244Trachtman H, Christen E, Cnaan A et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21(7): 989-994Trachtman H, Christen E, Cnaan A et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21(7): 989-994Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol 2003; 131(3): 528-535Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol 2003; 131(3): 528-535Monnens L, Molenaar J, Lambert PH et al. The complement system in hemolytic-uremic syndrome in childhood. N Engl J Med 1980; 13(4): 168-171Monnens L, Molenaar J, Lambert PH et al. The complement system in hemolytic-uremic syndrome in childhood. N Engl J Med 1980; 13(4): 168-171Robson WL, Leung AK, Fick GH et al. Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62(3): 296-299Robson WL, Leung AK, Fick GH et al. Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62(3): 296-299Keir LS, Saleem MA. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2014; 29(10): 1895-1902Keir LS, Saleem MA. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2014; 29(10): 1895-1902Thurman JM, Marians R, Emlen W et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4(12): 1920-1924Thurman JM, Marians R, Emlen W et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4(12): 1920-1924Angioi A, Fervenza FC, Sethi S et al. Diagnosis of complement alternative pathway disorders. Kidney Int 2016; 89(2): 278-288Angioi A, Fervenza FC, Sethi S et al. Diagnosis of complement alternative pathway disorders. Kidney Int 2016; 89(2): 278-288Monnens L, Samwel M, Lestijo BJ et al. Serum immunoglobulin levels in the hemolytic-uremic syndrome in children. Acta Paediatr Belg 1980; 33(3): 157-161Monnens L, Samwel M, Lestijo BJ et al. Serum immunoglobulin levels in the hemolytic-uremic syndrome in children. Acta Paediatr Belg 1980; 33(3): 157-161Лора Ш, Фремю-Бачи B (Loirat C, Fremeaux-Bacchi V). Атипичный гемолитико-уремический синдром. Нефрология 2012; 16(2): 16-48 [Atipichnij Gemolitiko-uremicheskij sindrom. Nefrologiya. 2012; 16(2): 16-48]Лора Ш, Фремю-Бачи B (Loirat C, Fremeaux-Bacchi V). Атипичный гемолитико-уремический синдром. Нефрология 2012; 16(2): 16-48 [Atipichnij Gemolitiko-uremicheskij sindrom. Nefrologiya. 2012; 16(2): 16-48]

The authors declare that there are no conflicts of interest present.